Health
U.K. says study supports delaying 2nd COVID-19 vaccine dose – Los Angeles Times
A study finds that the AstraZeneca-Oxford University vaccine cut coronavirus transmission by two-thirds and prevented COVID-19.
Britains health chief has hailed a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks, saying it supports the governments contentious strategy of delaying the second shot so it can protect more people quickly with a first dose.
Britains decision has been criticized as risky by other European countries, but Health Secretary Matt Hancock said Wednesday that the study backs the strategy that weve taken, and it shows the…
-
Noosa News18 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business21 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business18 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News18 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage